Charles Schwab Investment Management Inc Biote Corp. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Biote Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 39,116 shares of BTMD stock, worth $292,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,116
Previous 39,116
-0.0%
Holding current value
$292,196
Previous $193,000
17.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
56Shares Held
12.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$28.1 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$15 Million4.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY973KShares$7.27 Million0.0% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL838KShares$6.26 Million3.21% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $56.6M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...